Predicting effector genes for complex diseases and traits: your feedback needed!

Researchers who perform genome-wide association studies (GWAS) often aggregate and integrate multiple other evidence types in order to predict the effector (causal) genes at GWAS loci (see some examples). We distinguish these post-GWAS lists from other candidate gene lists that are based on, for example, rare or clinically relevant variation or on sources other than genetics. There are currently no community standards for organizing or sharing lists of predicted effector genes. This survey represents a first step towards developing the standards, infrastructure and incentives required to promote and enable sharing, interoperability, and updating of these lists. We hope to gather your input to help us shape the agenda for a hybrid workshop to be held in September 2024 (see below). This survey will be open through April 30, 2024.

Sign in to Google to save your progress. Learn more
Which terminology do you think is most appropriate for a gene that is predicted to be responsible for a genetic association? (all descriptors would be accompanied by "predicted")
Not appropriate
Appropriate
Most appropriate
Effector gene
Causal gene
Causative gene
Mechanistic gene
Functional gene
Candidate gene
Prioritized gene
The descriptor(s) chosen above, but referring to a transcript rather than a gene
Clear selection

If you have a strong opinion about which terms are appropriate or inappropriate, please explain your reasoning. Do you have suggestions for better ways to describe these genes?

How do you use, or plan to use, lists of predicted effector genes? (select all that apply)

Which effector gene lists are you interested in?

Where would you go to find these lists at the moment?

Please rate the potential barriers to using these lists.

This is a barrier
This is not a barrier
Lack of trust in other people’s work
Lack of transparency on methods used to derive them
Lack of provenance for underlying data
Lack of standardized confidence assertion
Lack of standardized ranking system
Difficult to find lists
Lack of a single "gold-standard" list for a trait
Clear selection
Please comment on any additional barriers to your making use of these lists.

Please rate how valuable you find these types of effector gene list:

1 (most valuable)
2
3
4
5
6 (least valuable)
Bioinformatics derived - one line of evidence
Bioinformatics derived - multiple lines of evidence
Manual curation derived - one line of evidence
Manual curation derived - multiple lines of evidence
Combination of bioinformatics and manual curation, with multiple lines of evidence
Any of the above as long as I know the data provenance and methodology
Clear selection
Should predicted effector gene lists based on the genes at GWAS loci be distinguished from candidate gene lists based on rare or clinically relevant variation or on sources other than genetics?
Clear selection

Thinking about scoring and categorization, which type of list do you prefer?

Thinking about the range of genes presented in a list, which type of list do you prefer?

Would it be valuable to have the ability to compare multiple lists?
Would you like to be able to interact with these lists, assigning different weights to different evidence types according to your judgement of the value of each evidence type?
Clear selection
Any other comments or suggestions?
Please tell us which of these categories apply to you.
Next
Clear form
Never submit passwords through Google Forms.
This form was created inside of Broad Institute of MIT and Harvard. Report Abuse